banner add

F.D.A. Delays Action on Closely Watched Alzheimer’s Drug

Eli Lilly’s donanemab was expected to be approved this month, but the agency has decided to convene a panel of independent experts to evaluate the drug’s safety and efficacy.

from NYT > Health https://ift.tt/uerDs2S
via IFTTT

No comments

Kennedy Says He Will Give HPV Vaccine Lawsuit Proceeds to His Son

Robert F. Kennedy Jr. also disclosed that he had reached at least one settlement agreement with a company or individual that has accused him...

Theme images by PLAINVIEW. Powered by Blogger.